Study of Fluoxetine in Autism

NCT00515320 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Autistic Disorder

Interventions

DRUG: Fluoxetine
DRUG: Placebo

Sponsor

Neuropharm

Collaborators

[object Object]